Phage treatment of human infections ST Abedon, SJ Kuhl, BG Blasdel, EM Kutter Bacteriophage 1 (2), 66-85, 2011 | 1137 | 2011 |
Pros and cons of phage therapy C Loc-Carrillo, ST Abedon Bacteriophage 1 (2), 111-114, 2011 | 1074 | 2011 |
Phage cocktails and the future of phage therapy BK Chan, ST Abedon, C Loc-Carrillo Future microbiology 8 (6), 769-783, 2013 | 1005 | 2013 |
Bacteriophage host range and bacterial resistance P Hyman, ST Abedon Advances in applied microbiology 70, 217-248, 2010 | 859 | 2010 |
Phage therapy in clinical practice: treatment of human infections E Kutter, D De Vos, G Gvasalia, Z Alavidze, L Gogokhia, S Kuhl, ... Current pharmaceutical biotechnology 11 (1), 69-86, 2010 | 840 | 2010 |
Lysogeny in nature: mechanisms, impact and ecology of temperate phages C Howard-Varona, KR Hargreaves, ST Abedon, MB Sullivan The ISME journal 11 (7), 1511-1520, 2017 | 682 | 2017 |
The Bacteriophages 2/e R Calendar, ST Abedon Oxford University Press, 2006 | 615* | 2006 |
Lysis from without ST Abedon Bacteriophage 1 (1), 46-49, 2011 | 402 | 2011 |
Phage therapy pharmacology ST Abedon, C Thomas-Abedon Current pharmaceutical biotechnology 11 (1), 28-47, 2010 | 354 | 2010 |
Practical methods for determining phage growth parameters P Hyman, ST Abedon Bacteriophages: methods and protocols, volume 1: isolation, characterization …, 2009 | 315 | 2009 |
Bacteriophage latent-period evolution as a response to resource availability ST Abedon, TD Herschler, D Stopar Applied and environmental microbiology 67 (9), 4233-4241, 2001 | 307 | 2001 |
Bacteriophage ecology: population growth, evolution, and impact of bacterial viruses ST Abedon Cambridge University Press, 2008 | 274 | 2008 |
Phage therapy pharmacology: phage cocktails BK Chan, ST Abedon Advances in Applied Microbiology, 1, 2012 | 234 | 2012 |
Diversity of phage infection types and associated terminology: the problem with ‘Lytic or lysogenic’ Z Hobbs, ST Abedon FEMS microbiology letters 363 (7), fnw047, 2016 | 229 | 2016 |
Bacteriophages and their enzymes in biofilm control BK Chan, ST Abedon Current pharmaceutical design 21 (1), 85-99, 2015 | 220 | 2015 |
Editorial: Phage therapy: past, present and future ST Abedon, P García, P Mullany, R Aminov Frontiers in microbiology 8, 981, 2017 | 207 | 2017 |
Experimental examination of bacteriophage latent-period evolution as a response to bacterial availability ST Abedon, P Hyman, C Thomas Applied and environmental microbiology 69 (12), 7499-7506, 2003 | 192 | 2003 |
Bacteriophage plaques: theory and analysis ST Abedon, J Yin Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization …, 2009 | 178 | 2009 |
Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and-sensitive monoclonal antibodies. CC Broder, PL Earl, D Long, ST Abedon, B Moss, RW Doms Proceedings of the National Academy of Sciences 91 (24), 11699-11703, 1994 | 168 | 1994 |
Phage evolution and ecology ST Abedon Advances in applied microbiology 67, 1-45, 2009 | 166 | 2009 |